IL321586A - Amylin receptor agonists - Google Patents

Amylin receptor agonists

Info

Publication number
IL321586A
IL321586A IL321586A IL32158625A IL321586A IL 321586 A IL321586 A IL 321586A IL 321586 A IL321586 A IL 321586A IL 32158625 A IL32158625 A IL 32158625A IL 321586 A IL321586 A IL 321586A
Authority
IL
Israel
Prior art keywords
compound
receptor agonist
amylin receptor
absent
formula
Prior art date
Application number
IL321586A
Other languages
English (en)
Hebrew (he)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US18/512,512 external-priority patent/US12116388B2/en
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL321586A publication Critical patent/IL321586A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL321586A 2022-12-22 2023-12-21 Amylin receptor agonists IL321586A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22215958 2022-12-22
US18/512,512 US12116388B2 (en) 2022-12-22 2023-11-17 Amylin receptor agonists
PCT/EP2023/087353 WO2024133739A1 (en) 2022-12-22 2023-12-21 Amylin receptor agonists

Publications (1)

Publication Number Publication Date
IL321586A true IL321586A (en) 2025-08-01

Family

ID=89542238

Family Applications (1)

Application Number Title Priority Date Filing Date
IL321586A IL321586A (en) 2022-12-22 2023-12-21 Amylin receptor agonists

Country Status (12)

Country Link
EP (1) EP4638480A1 (https=)
JP (1) JP2025542410A (https=)
KR (1) KR20250127104A (https=)
CN (1) CN120435491A (https=)
AU (1) AU2023411346A1 (https=)
CL (1) CL2025001805A1 (https=)
CO (1) CO2025008319A2 (https=)
IL (1) IL321586A (https=)
JO (1) JOP20250144A1 (https=)
MX (1) MX2025007124A (https=)
TW (1) TW202428309A (https=)
WO (1) WO2024133739A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008006A1 (en) 1992-09-30 1994-04-14 Zymogenetics, Inc. Human calcitonin receptor
ES2401965T3 (es) 2009-02-19 2013-04-25 Novo Nordisk A/S Modificación de Factor VIII
JP6121992B2 (ja) 2011-06-10 2017-04-26 ノヴォ ノルディスク アー/エス ポリペプチド
AR097701A1 (es) * 2013-09-19 2016-04-13 Zealand Pharma As Análogos de amilina
JP6898518B2 (ja) 2018-02-02 2021-07-07 ノヴォ ノルディスク アー/エス Glp−1アゴニスト、n−(8−(2−ヒドロキシベンゾイル)アミノ)カプリル酸の塩及び滑沢剤を含む固形組成物
TWI829687B (zh) 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物

Also Published As

Publication number Publication date
TW202428309A (zh) 2024-07-16
KR20250127104A (ko) 2025-08-26
CN120435491A (zh) 2025-08-05
EP4638480A1 (en) 2025-10-29
CO2025008319A2 (es) 2025-07-17
CL2025001805A1 (es) 2025-09-26
MX2025007124A (es) 2025-07-01
JP2025542410A (ja) 2025-12-25
AU2023411346A1 (en) 2025-07-24
WO2024133739A1 (en) 2024-06-27
JOP20250144A1 (ar) 2025-06-16

Similar Documents

Publication Publication Date Title
TWI882061B (zh) 介白素-23受體之肽抑制劑及其治療發炎性疾病之用途
AU2022209221B2 (en) Controlled-release CNP agonists with increased NEP stability
RU2736637C9 (ru) Пептидные ингибиторы рецептора интерлейкина-23 для перорального приема и их применение для лечения воспалительных заболеваний кишечника
JP2025134806A (ja) インターロイキン23受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用
JP5819586B2 (ja) 選択的グルカゴン様ペプチド−2(glp−2)類似体
AU2022221482B2 (en) Controlled-release CNP agonists with low NPR-C binding
AU2018210174A1 (en) Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
RU2008141280A (ru) Агонисты рецептора нейромедина u и их применение
JP2023530515A5 (https=)
EA035733B1 (ru) Пептидные ингибиторы рецептора интерлейкина-23 и их применение для лечения воспалительных заболеваний
JP2022540154A (ja) インターロイキン-23受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用
CN115925790A (zh) 用于合成α4β7肽拮抗剂的方法
MY161450A (en) Double-acylated glp-1 derivatives
AU2022224732A1 (en) Controlled-release CNP agonists with reduced side-effects
JP2023551122A5 (https=)
WO2020230780A1 (ja) Ras阻害ペプチド
IL321586A (en) Amylin receptor agonists
KR102520348B1 (ko) 페길화 생활성 펩타이드 및 그의 용도
SK150196A3 (en) Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use
JP2024170574A (ja) ヘマグルチニン結合ペプチド
JP2005060315A (ja) 製剤組成物
CN112165953A (zh) 用作爱帕琳肽受体拮抗剂的化合物
JP2024527220A5 (https=)
KR101412119B1 (ko) 생리적 안정성을 증가시킨 par―2 활성화 펩타이드 및 이를 함유하는 약제학적 조성물
TW202542175A (zh) 人類介白素(il)-17細胞激素結合肽